Advanced search
Publication Cover
Acta Oncologica Volume 48, 2009 - Issue 7
Journal homepage
654
Views
5
CrossRef citations to date
0
Altmetric
Original Article

No direct effects of erythropoietin beta on a head and neck squamous cell carcinoma cell line which is growth stimulated in vivo

Yutaka Sasaki Department of Oto-rhino-laryngology, Head and Neck Surgery, Lund University, Lund, Sweden; Department of Oto-rhino-laryngology, Head and Neck Surgery, Hamamatsu University School of Medicine, Japan
,
Elisabeth Kjellén Department of Oncology, Lund University, Lund, Sweden
,
Hiroyuki Mineta Department of Oto-rhino-laryngology, Head and Neck Surgery, Hamamatsu University School of Medicine, Japan
,
Johan Wennerberg Department of Oto-rhino-laryngology, Head and Neck Surgery, Lund University, Lund, Sweden
&
Lars Ekblad Department of Oncology, Lund University, Lund, SwedenCorrespondence[email protected].
Pages 1062-1069 | Received 27 Jan 2009, Published online: 08 Oct 2009

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Steve Elliott & Angus M Sinclair. (2012) The effect of erythropoietin on normal and neoplastic cells. Biologics: Targets and Therapy 6, pages 163-189.
Read now

Articles from other publishers (4)

Marius G. Bredell, Jutta Ernst, Ilhem El-Kochairi, Yuliya Dahlem, Kristian Ikenberg & Desiree M. Schumann. (2016) Current relevance of hypoxia in head and neck cancer. Oncotarget 7:31, pages 50781-50804.
Crossref
Gustaf Lindgren, Lars Ekblad, Johan Vallon-Christersson, Elisabeth Kjellén, Maria Gebre-Medhin & Johan Wennerberg. (2014) Erythropoietin suppresses the activation of pro-apoptotic genes in head and neck squamous cell carcinoma xenografts exposed to surgical trauma. BMC Cancer 14:1.
Crossref
Steve Elliott, Susan Swift, Leigh Busse, Sheila Scully, Gwyneth Van, John Rossi & Carol Johnson. (2013) Epo Receptors Are Not Detectable in Primary Human Tumor Tissue Samples. PLoS ONE 8:7, pages e68083.
Crossref
Yihai Cao. (2013) Erythropoietin in cancer: a dilemma in risk therapy. Trends in Endocrinology & Metabolism 24:4, pages 190-199.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.